Prognostic of Dysfunctional Breathing in Long Covid: a Follow up Study
NCT05217875 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2022-02-01
Summary
Dysfunctional breathing might participate to dyspnoea in long COVID-19. This study investigate the prognosis of patients diagnosed with dysfunctional breathing after SARS-CoV-2 infection in our center.
Conditions
- COVID-19
- Dysfunctional Breathing
Sponsors & Collaborators
-
Hôpital du Valais
lead OTHER
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-01
- Primary Completion
- 2022-06-30
- Completion
- 2022-08-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19
NCT04610554 ·Status: COMPLETED
-
Long COVID and Post-exertional Pulmonary Diffusion
NCT05430503 ·Status: COMPLETED
-
Prevalence and Characterization of Persistent Dyspnea After Hospitalization
NCT03798158 ·Status: UNKNOWN
-
Autonomic Function in Patients With COPD
NCT05667311 ·Status: COMPLETED
-
Dyspnea and Idiopathic Pulmonary Fibrosis
NCT04864990 ·Status: COMPLETED
-
Demonstration of Broncholytic Effects in Subjects With Obstructive Airway Diseases by Low Frequency Ultrasound
NCT01080924 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Exhaled Breath Condensate in the Diagnosis of Invasive Pulmonary Aspergillosis
NCT01247142 ·Status: COMPLETED
-
Ultrasound of the Diaphragm Excursion Ratio as Physiological Biomarker in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
NCT07259174 ·Status: RECRUITING
-
Breathlessness Patterns in Patients With Cancer, COPD and Heart Failure: an fMRI Feasibility Study
NCT07319039 ·Status: RECRUITING
-
Diagnostic and Prognostic Value of New Biomarkers in Patients With Heart Disease
NCT01374880 ·Status: UNKNOWN
-
Dyspnea in Patients With Pulmonary Fibrosis
NCT00611182 ·Status: COMPLETED
-
Development of a New Tool for Dyspnea Measurement in Chronic Respiratory Diseases
NCT02229994 ·Status: COMPLETED
-
Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease
NCT01318174 ·Status: COMPLETED
-
Target Validation and Discovery in Idiopathic Bronchiectasis
NCT03750734 ·Status: COMPLETED
-
Monitoring Chronic Obstructive Pulmonary Disease Patients at Home by a Forced Oscillation Technique Device
NCT01552031 ·Status: UNKNOWN
-
Prevalence and Reversibility of Lung Hyperinflation in Asthma
NCT01573364 ·Status: COMPLETED
-
The Long Term Effects of COVID on Pulmonary Function
NCT05077982 ·Status: COMPLETED
-
Pulmonary Function, Chronic Obstructive Pulmonary Disease (COPD) Prevalence, and Systemic Inflammation in Chronic Heart Failure With or Without COPD
NCT01429376 ·Status: COMPLETED ·Phase: NA
-
Morphine for Dyspnea in Pulmonary Fibrosis
NCT04497831 ·Status: UNKNOWN ·Phase: PHASE3
-
Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)
NCT04435327 ·Status: COMPLETED
-
Basics in Acute Shortness of Breath EvaLuation (BASEL V) Study
NCT01831115 ·Status: ACTIVE_NOT_RECRUITING
-
Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients
NCT02058602 ·Status: COMPLETED ·Phase: PHASE1
-
Frequency-time Analysis of Pathological Lung Sounds: Detection and Quantification of Pathological Sounds in Patients With Cystic Fibrosis, Pulmonary Fibrosis or COPD (Chronic Obstructive Pulmonary Disease)
NCT06399094 ·Status: TERMINATED
-
Late Respiratory Consequences of SARS-CoV-2 Pneumonia
NCT05812196 ·Status: RECRUITING
-
Biomarkers in Dyspnea
NCT03056547 ·Status: COMPLETED ·Phase: NA